1046 related articles for article (PubMed ID: 18315691)
21. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
Ko BS; Lim WS; Kim HJ; Yu JH; Lee JW; Kwan SB; Lee YM; Son BH; Gong GY; Ahn SH
Ann Surg Oncol; 2012 Jan; 19(1):212-6. PubMed ID: 21633867
[TBL] [Abstract][Full Text] [Related]
22. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ
Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928
[TBL] [Abstract][Full Text] [Related]
23. [Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer].
Takács T; Szentpáli K; Paszt A; Ormándi K; Lázár M; Pálka I; Kahán Z; Lázár G
Magy Onkol; 2006; 50(3):247-51. PubMed ID: 17099786
[TBL] [Abstract][Full Text] [Related]
24. Results of 23,810 cases of ductal carcinoma-in-situ.
Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
[TBL] [Abstract][Full Text] [Related]
25. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
26. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
27. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
28. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
29. [Surgical aspects of breast cancer screening at our hospital].
Márkus B; Bajner A; Csejtei A; Firisz B; Hegedus A; Kocsis E; Kovács B; Pintér G; Tóth C
Magy Seb; 2006 Oct; 59(5):375-82. PubMed ID: 17201346
[TBL] [Abstract][Full Text] [Related]
30. The use of sentinel lymph node biopsy in ductal carcinoma in situ.
Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W
Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339
[TBL] [Abstract][Full Text] [Related]
31. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
32. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
33. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
34. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
35. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy.
Kiluk JV; Santillan AA; Kaur P; Laronga C; Meade T; Ramos D; Cox CE
Ann Surg Oncol; 2008 Dec; 15(12):3402-6. PubMed ID: 18820974
[TBL] [Abstract][Full Text] [Related]
37. An argument against routine sentinel node mapping for DCIS.
Farkas EA; Stolier AJ; Teng SC; Bolton JS; Fuhrman GM
Am Surg; 2004 Jan; 70(1):13-7; discussion 17-8. PubMed ID: 14964539
[TBL] [Abstract][Full Text] [Related]
38. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
[TBL] [Abstract][Full Text] [Related]
39. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
40. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]